Pfizer (PFE) May 2 weekly 23 straddle into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Ovintiv adds 41,000 acres in Permian and Montney deals
- Russia says it could strike UK military targets in response to Kyiv's use of British missiles
JPMorgan Reiterates Neutral Rating on Pfizer (PFE)
April 29, 2025 4:14 PM EDTJPMorgan analyst Chris Schott reiterated a Neutral rating and $30.00 price target on Pfizer (NYSE: PFE).
The analyst comments "Exiting PFEs 1Q results and our follow up with the company, we want to provide our key takeaways. On the qtr, PFE's sales came in below expectations (which is not surprising as... More
